Hyperprogression in cancer patients on immunotherapeutic agents.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.3575
Abstract: 3575Background: Patients (pts) treated with checkpoint inhibitors (CPI) may uncommonly experience accelerated progression in their tumor burden when compared to their rate of progression prior to r... read more here.
Keywords: patients immunotherapeutic; hyperprogression cancer; oncology; cancer patients ... See more keywords